Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex

Acta Neuropathologica

Volumn 123, Issue 5, 2012, Pages 685-693

  Marcotte, Leah ^a   Aronica, Eleonora ^b,c   Baybis, Marianna ^a   Crino, Peter B ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Autism; mTOR; Tuberous sclerosis; Tuberous sclerosis complex; Tubers

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN S6;

ADOLESCENT; ADULT; ARTICLE; AUTISM; BRAIN CORTEX; BRAIN INJURY; CADAVER; CELL STRUCTURE; CHILD; CONTROLLED STUDY; CYTOARCHITECTURE; EPILEPTIC STATE; FEMALE; GENOTYPE; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; OCCIPITAL LOBE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; TISSUE SECTION; TUBEROUS SCLEROSIS;

ADOLESCENT; ADULT; CEREBRAL CORTEX; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HUMANS; MALE; MUTATION; NEURONS; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 84862677084     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-012-0950-3     Document Type: Article

References (25)

1. Arulrajah S, Ertan G, Jordan L et al (2009) Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex. Neuroradiology 51:781-786
2. Baybis M, Yu J, Lee A et al (2004) mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 56:478-487 (Pubitemid 39319337)
3. Boer K, Troost D, Jansen F et al (2008) Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology 28:577-590
4. Bollo RJ, Kalhorn SP, Carlson C, Haegeli V, Devinsky O, Weiner HL (2008) Epilepsy surgery and tuberous sclerosis complex: special considerations. Neurosurg Focus 25:E13
5. Chan JA, Zhang H, Roberts PS et al (2004) Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J Neuropathol Exp Neurol 63:1236-1242 (Pubitemid 39603395)
6. Chou IJ, Lin KL, Wong AM et al (2008) Neuroimaging correlation with neurological severity in tuberous sclerosis complex. Eur J Paediatr Neurol 12:108-112 (Pubitemid 351305201)
7. Crino PB, Nathanson KL, Henske EP (2006) The tuberous sclerosis complex. N Engl J Med 355:1345-1356
8. Doherty C, Goh S, Young Poussaint T, Erdag N, Thiele EA (2005) Prognostic significance of tuber count and location in tuberous sclerosis complex. J Child Neurol 20:837-841 (Pubitemid 43124477)
9. Eberhart CG, Copeland J, Abel TW (2006) Brief report: S6 ribosomal protein phosphorylation in autistic frontal cortex and cerebellum: a tissue array analysis. J Autism Dev Disord 36:1131-1135 (Pubitemid 46020365)
10. Ehninger D, de Vries PJ, Silva AJ (2009) From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis. J Intellect Disabil Res 53:838-851
11. Fukutani Y, Yasuda M, Saitoh C et al (1992) An autopsy case of tuberous sclerosis. Histological and immunohistochemical study. Histol Histopathol 7:709-714
12. Gallagher A, Grant EP, Madan N, Jarrett DY, Lyczkowski DA, Thiele EA (2010) MRI findings reveal three different types of tubers in patients with tuberous sclerosis complex. J Neurol 257:1373-1381
13. Major P, Rakowski S, Simon MV (2009) Are cortical tubers epileptogenic? Evidence from electrocorticography. Epilepsia 50:147-154
14. Miyata H, Chiang AC, Vinters HV (2004) Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis. Ann Neurol 56:510-519 (Pubitemid 39319341)
15. Mizuguchi M, Takashima S (2001) Neuropathology of tuberous sclerosis. Brain Dev 23(7):508-515 (Pubitemid 32999117)
16. Naramoto A, Itoh N, Nakano M, Shigematsu H (1989) An autopsy case of tuberous sclerosis associated with primary pericardial mesothelioma. Acta Pathol Jpn 39:400-406 (Pubitemid 19204608)
17. Nixon JR, Miller GM, Okazaki H, Gomez MR (1989) Cerebral tuberous sclerosis: postmortem magnetic resonance imaging and pathologic anatomy. Mayo Clin Proc 64:305-311 (Pubitemid 19123105)
18. Pou-Serradell A, Pascual J, Ugarte A, Florensa R, Soler L (1979) A study of 14 cases of Bourneville's tuberous sclerosis, including two pathological reports and seven cases investigated by computer tomography (author's transl). Rev Neurol (Paris) 135:693-703
19. Ridler K, Bullmore ET, De Vries PJ (2001) Widespread anatomical abnormalities of grey and white matter structure in tuberous sclerosis. Psychol Med 31:1437-1446 (Pubitemid 33040367)
20. Ridler K, Suckling J, Higgins NJ (2007) Neuroanatomical correlates of memory deficits in tuberous sclerosis complex. Cereb Cortex 17:261-271 (Pubitemid 46052765)
21. Raznahan A, Higgins NP, Griffiths PD, Humphrey A, Yates JR, Bolton PF (2007) Biological markers of intellectual disability in tuberous sclerosis. Psychol Med 37:1293-1304 (Pubitemid 47244859)
22. Scheithauer BW, Reagan TJ (1999) Neuropathology. In: Gomez MR (ed) Tuberous sclerosis complex, 3rd edn. Oxford University Press, Oxford, pp 101-144
23. Talos DM, Kwiatrowski DJ, Cordero K, Black PM, Jensen FE (2008) Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol 63:454-465 (Pubitemid 351614711)
24. Wong V, Khong PL (2006) Tuberous sclerosis complex: correlation of magnetic resonance imaging (MRI) findings with comorbidities. J Child Neurol 21:99-105 (Pubitemid 43772644)
25. Zaroff CM, Bar WB, Carlson C et al (2006) Mental retardation and relation to seizure and tuber burden in tuberous sclerosis complex. Seizure 15:558-562 (Pubitemid 44296068)